Drug Safety Settlement
Japanese drugmaker Daiichi Sankyo Co, which bought control of Ranbaxy Laboratories in 2008, said it believes unnamed former shareholders of the company hid information regarding U.S. regulatory probes into Ranbaxy. Full Article
Confused while buying stocks? Get buy, sell or hold recommendations from VantageTrade. Full Coverage
JP Morgan, Barclays upgrade Infosys to overweight
MUMBAI (Reuters) - J.P.Morgan and Barclays Capital upgraded their ratings on Infosys to "overweight", citing an expected improvement in earnings after the software services exporter posted better-than-expected results and revenue outlook on Friday.
Barclays raised Infosys Ltd (INFY.NS) to "overweight" from "equal weight", while J.P.Morgan raised its rating from "neutral."
(Reporting by Abhishek Vishnoi and Rafael Nam; Editing by Subhranshu Sahu)
- Tweet this
- Share this
- Digg this